Skip to main content
logo
VitaNova Life Sciences Corporation (VNOV)
OTCMKTS · Delayed Price · Currency is USD
1.380
0.00 (0.00%)
Apr 20, 2026, 12:00 PM EST

VitaNova Life Sciences Balance Sheet

Millions USD. Fiscal year is May - Apr.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Cash & Equivalents
1.60.780.590.010.02
Cash & Short-Term Investments
1.60.780.590.010.02
Cash Growth
104.04%32.00%6694.64%-62.22%-
Receivables
0.731.27---
Inventory
0.110.040.13--
Other Current Assets
00.160.47--
Total Current Assets
2.432.261.190.010.02
Long-Term Deferred Tax Assets
0.02----
Total Assets
2.452.261.190.010.02

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Accounts Payable
0.21-0.060.05-
Accrued Expenses
0.080.06--0.05
Short-Term Debt
--00.020.01
Current Income Taxes Payable
0.110.290.06--
Other Current Liabilities
--0.01--
Total Current Liabilities
0.40.350.140.070.06
Total Liabilities
0.40.350.140.070.06

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Common Stock
0.010.010.030.010.01
Additional Paid-In Capital
1.031.031.010.060.06
Retained Earnings
0.830.870.02-0.12-0.1
Comprehensive Income & Other
0.1800--
Shareholders' Equity
2.051.911.06-0.06-0.03
Total Liabilities & Equity
2.452.261.190.010.02

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Total Debt
--00.020.01
Net Cash (Debt)
1.60.780.59-0.010.01
Net Cash Growth
104.04%32.67%---
Net Cash Per Share
0.190.090.17-0.000.01
Filing Date Shares Outstanding
8.348.348.341.961.96
Total Common Shares Outstanding
8.348.348.341.961.96
Working Capital
2.031.911.06-0.06-0.03
Book Value Per Share
0.250.230.13-0.03-0.02
Tangible Book Value
2.051.911.06-0.06-0.03
Tangible Book Value Per Share
0.250.230.13-0.03-0.02